Trials / Completed
CompletedNCT01564290
Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children
Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children: A Randomized Double-blind Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Centro Pediatrico Albina de Patino · Academic / Other
- Sex
- All
- Age
- 10 Months – 36 Months
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effect of probiotic yogurt in acute watery diarrhea in children. The investigators will compare the effect of two different probiotics products.
Detailed description
Background: Acute Gastroenteritis is one of the most and frequent disease in the childhood, considering the advances in treatment, Lactobacillus Rahmnosus has being well described as a probiotic who reduces the number of days of hospitalization and also de the severity. Objectives: To evaluate the effect of the probiotic yogurt in the treatment of children who are between 10 months and 3 years old with acute non-dysenteric diarrhea. Methods: A randomized clinical trial, controlled, double-blind. The investigators will have two groups of patients : One group will receive Lactobacillus Rahmnosus in a yogurt presentation and the other one will receive Sacharomyces boulardii in a lyophilized form ; the parameters of evaluation are going to be the number of diarrhea stools by day, number of vomiting episodes, hours with fever, nutritional and immunization state.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic yogurt | Lactobacilus Rhamnonsus 100000000 UFC per mL. Dosage 50 mL twice daily fo 5 days. |
| DRUG | Placebo probiotic | Lyophilized probiotic, containing 250 mg per sachet dosage to about 2 times a day for 5 days. |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2011-08-01
- Completion
- 2012-02-01
- First posted
- 2012-03-27
- Last updated
- 2012-03-27
Locations
1 site across 1 country: Bolivia
Source: ClinicalTrials.gov record NCT01564290. Inclusion in this directory is not an endorsement.